Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Aga Khan University | OTHER |
| Aga Khan Health Services | OTHER |
| The Aga Khan Foundation | OTHER |
| Family Care International |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This community-based trial will study misoprostol for the prevention of postpartum hemorrhage in rural Pakistan. Traditional birth attendants assisting home deliveries will administer study tablets (600 mcg oral misoprostol or placebo) in the third stage of labor to women participating in the trial. Blood loss, hemoglobin levels, side effects, and other variables will be evaluated.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Misoprostol | Drug | 600 mcg oral misoprostol administered during third stage of labor |
| Measure | Description | Time Frame |
|---|---|---|
| Postpartum hemorrhage (blood loss >or= 500 mL) | Measured at 1 hour postpartum or until active bleeding has stopped | |
| Drop in hemoglobin > 2 g/dL from pre to post-delivery | Hemoblobin (Hb) level measured 3-5 days after delivery |
| Measure | Description | Time Frame |
|---|---|---|
| Intermediate and severe PPH (blood loss >or=750 mL and >or= than 1000 mL) | Blood loss measured at 1 hr postpartum or until active bleeding stopped | |
| Mean blood loss | blood loss measured at 1 hr postpartum or until active bleeding stopped |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Gijs Walraven, MD | Aga Khan Health Services | Principal Investigator |
| Juanita Hatcher, PhD | Aga Khan University | Principal Investigator |
| Naushaba Mobeen, MD | Aga Khan University | Study Director |
| Jennifer Blum, MPH | Gynuity Health Projects | Study Director |
| Zafar Ahmad, MD | Aga Khan Health Services | Study Director |
| Nadeem Zuberi, MD | Aga Khan University | Study Director |
| Jill Durocher | Gynuity Health Projects | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Home delivery setting | Chitral | Chitral District | Pakistan |
Not provided
| Label | URL |
|---|---|
| Gynuity Health Projects | View source |
Not provided
Not provided
| ID | Term |
|---|---|
| D006473 | Postpartum Hemorrhage |
| D000740 | Anemia |
| ID | Term |
|---|---|
| D007744 | Obstetric Labor Complications |
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D016595 | Misoprostol |
| ID | Term |
|---|---|
| D011459 | Prostaglandins E, Synthetic |
| D011465 | Prostaglandins, Synthetic |
| D011453 | Prostaglandins |
| D015777 | Eicosanoids |
Not provided
Not provided
| OTHER |
Not provided
Not provided
Not provided
Not provided
| Side effects experienced among recently delivered mothers | Interviews conducted 1 day post-delivery |
| Anemia (<9 g/dL and <11 g/dL) | Postpartum hemoglobin assessed 3 days post-delivery |
| D011644 | Puerperal Disorders |
| D014592 | Uterine Hemorrhage |
| D006470 | Hemorrhage |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D006402 | Hematologic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
| D005231 |
| Fatty Acids, Unsaturated |
| D005227 | Fatty Acids |
| D008055 | Lipids |
| D012898 | Autacoids |
| D018836 | Inflammation Mediators |
| D001685 | Biological Factors |